Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder
Clinical Microbiology and Infection · 2023
DOI: 10.1016/j.cmi.2023.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Alysse G Wurcel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, MA, USA; Tufts University School of Me…. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Substance-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: AHRQ HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, MA, USA; Tufts University School of Medicine, Boston, MA, USA.
- Division of Public Health, Infectious Diseases and Occupational Medicine, Departments of Medicine and Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA.
- Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
- Institute for Infectious Diseases, University of Bern, Bern, Switzerland. Electronic address: parham.sendi@unibe.ch.
Förderung
- AHRQ HHS
Zitieren
APA
Wurcel, A. G., DeSimone, D. C., Marks, L., Baddour, L. M., & Sendi, P. (2023). Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.04.005
Vancouver
Wurcel AG, DeSimone DC, Marks L, Baddour LM, Sendi P. Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.04.005
BibTeX
@article{Wurcel2023,
author = {Wurcel, Alysse G and DeSimone, Daniel C and Marks, Laura and Baddour, Larry M and Sendi, Parham},
title = {Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder},
journal = {Clinical Microbiology and Infection},
year = {2023},
doi = {10.1016/j.cmi.2023.04.005}
}
EUVIMED